BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2509)

  • 1. The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.
    Feinstein PA; Kaplan SR; Thayer WR
    Gastroenterology; 1976 Feb; 70(2):181-5. PubMed ID: 2509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C3 and C4 complement components in ulcerative colitis and Crohn's disease.
    Ward M; Eastwood MA
    Digestion; 1975; 13(1-2):100-3. PubMed ID: 1201816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral immune system activity in inflammatory bowel disease.
    Teisberg P; Gjone E
    Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral immune system in inflammatory bowel disease: I. Complement levels.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1977 Sep; 18(9):749-53. PubMed ID: 604196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement alterations in inflammatory bowel disease.
    Lake AM; Stitzel AE; Urmson JR; Walker WA; Spitzer RE
    Gastroenterology; 1979 Jun; 76(6):1374-9. PubMed ID: 437435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum complement levels in patients with gastrointestinal disease.
    Ross IN; Thompson RA; Montgomery RD; Asquith P
    J Clin Pathol; 1979 Aug; 32(8):798-801. PubMed ID: 512040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 metabolism in ulcerative colitis and Crohn's disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Clin Exp Immunol; 1977 Jun; 28(3):490-5. PubMed ID: 891024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
    Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
    Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphism of complement C3 in chronic inflammatory bowel disease. Predominance of the C3F gene in Crohn's disease.
    Elmgreen J; Sørensen H; Berkowicz A
    Acta Med Scand; 1984; 215(4):375-8. PubMed ID: 6731047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercatabolism of complement in Crohn's disease--assessment of circulating C3c.
    Elmgreen J; Berkowicz A; Sørensen H
    Acta Med Scand; 1983; 214(5):403-7. PubMed ID: 6660048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings: Serum complement components C3 and C4 in inflammatory bowel disease.
    Ward M; Eastwood MA
    Gut; 1974 Oct; 15(10):835. PubMed ID: 4215646
    [No Abstract]   [Full Text] [Related]  

  • 14. Complement inhibitors and immunoconglutinins in ulcerative colitis and Crohn's disease.
    Potter BJ; Brown DJ; Watson A; Jewell DP
    Gut; 1980 Dec; 21(12):1030-4. PubMed ID: 6450718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced local production of complement components in the small intestines of patients with Crohn's disease.
    Ahrenstedt O; Knutson L; Nilsson B; Nilsson-Ekdahl K; Odlind B; Hällgren R
    N Engl J Med; 1990 May; 322(19):1345-9. PubMed ID: 2325733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial occurrence of complement dysfunction in Crohn's disease: correlation with intestinal symptoms and hypercatabolism of complement.
    Elmgreen J; Both H; Binder V
    Gut; 1985 Feb; 26(2):151-7. PubMed ID: 3967833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological differential diagnosis of inflammatory colonic diseases.
    Schneider HM; Loos M; Störkel S; Gross M
    Histopathology; 1984 Jul; 8(4):583-8. PubMed ID: 6332771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alternative pathway of complement activation in the neonate.
    Feinstein PA; Kaplan SR
    Pediatr Res; 1975 Oct; 9(10):803-6. PubMed ID: 1103071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Complement in inflammatory bowel disease.
    Hodgson HJ; Potter BJ; Jewell DP
    Gut; 1975 Oct; 16(10):833-4. PubMed ID: 1205305
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of the alternative pathway of the complement system by radiographic contrast media.
    Arroyave CM; Bhat KN; Crown R
    J Immunol; 1976 Nov; 117(5 Pt.2):1866-9. PubMed ID: 993582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.